Related Experiment Videos
Recovery of function in spinalized, neonatal rats
J W Commissiong1, Y Sauve, K Csonka
1Department of Physiology, McGill University, Montreal, Quebec, Canada.
Brain Research Bulletin
|July 1, 1991
Summary
GM1 ganglioside treatment significantly improved hindlimb function in spinalized neonatal rats. This functional recovery was observed when bridging the spinal cord, suggesting a novel therapeutic approach for spinal cord injury.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Spinal Cord Injury Research
Background:
- Neonatal rat spinal cord injury (SCI) models are crucial for understanding recovery mechanisms.
- Previous attempts to bridge spinal cord transections with fetal tissue showed limited success.
Purpose of the Study:
- To investigate the efficacy of bridging neonatal rat spinal cords with fetal tissue and GM1 ganglioside treatment.
- To explore potential mechanisms underlying functional recovery after neonatal SCI.
Main Methods:
- Neonatal rats underwent spinalization on postnatal day 14.
- Spinal cord transections were bridged with E16 fetal spinal cord tissue.
- Animals received either saline or GM1 ganglioside treatment post-bridging.
Main Results:
- Spinalization alone resulted in minimal hindlimb functional recovery.
- Bridging with fetal tissue did not enhance recovery.
- GM1 ganglioside treatment in bridged animals significantly improved hindlimb function compared to saline controls (p < 0.05).
- Fetal tissue transplants exhibited poor survival.
Conclusions:
- GM1 ganglioside treatment promotes functional recovery after neonatal rat SCI.
- Recovery may be mediated by hindlimb afferents activating central pattern generators, not descending fiber regrowth.
- GM1 ganglioside represents a promising therapeutic strategy for spinal cord repair.